IONIS® Neurology Webcast July 14, 2020 Forward Looking Language Statement This presentation includes forward-looking statements regarding our business, financial guidance and the therapeutic and commercial potential of SPINRAZA® (nusinersen) and Ionis' technologies and products in development, including Ionis' neurology franchise. Any statement describing Ionis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk state ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) BMO 2020 Prescriptions for Success Healthcare Conference June 23, 2020 2:00 PM ET Company Participants Eric Swayze - SVP of Research Wade Walke - Head, IR Conference Call Participants Do Kim - BMO Capital Markets Do Kim Good afternoon. My name is Do Kim. I'm one of the Biotech Analyst at BMO. For next fireside chat, we have with us, Eric Swayze, SVP Research at Ionis Pharmaceuticals and Wade Walke, Head of Investor Relations. Could you start by providing us a brief ...